Changeflow GovPing Healthcare & Life Sciences Netrin-1 peptide amphiphiles treat central nerv...
Routine Notice Added Draft

Netrin-1 peptide amphiphiles treat central nervous system injury

Favicon for changeflow.com USPTO Patent Applications - Peptides (C07K)
Published
Detected
Email

Summary

USPTO published patent application US20260092252A1 for Netrin-1 mimetic peptide amphiphiles for treating central nervous system injury. The application covers peptide compositions and methods of use. Inventors include Samuel Isaac Stupp, Cara Stephanie Smith, and Zaida Alvarez Pinto.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The USPTO published patent application US20260092252A1 for Netrin-1 mimetic peptide amphiphiles, which are self-assembling molecules that mimic the natural netrin-1 protein for therapeutic use. The application covers nanofibers displaying bioactive PAs and methods of treating central nervous system injury using these compositions.

For companies developing CNS therapeutics or peptide-based treatments, this published application represents a potential blocking patent that could affect freedom to operate in this technology space. The filing date was September 30, 2025, with Application No. 19345142. No immediate compliance actions are required, but R&D teams should review for potential IP conflicts.

Archived snapshot

Apr 2, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

NETRIN-1 MIMETIC PEPTIDE AMPHIPHILES

Application US20260092252A1 Kind: A1 Apr 02, 2026

Inventors

Samuel Isaac Stupp, Cara Stephanie Smith, Zaida Alvarez Pinto

Abstract

Provided herein are netrin-1 mimetic peptide amphiphiles (PAs) comprising a netrin-1 mimetic sequence, nanofibers displaying the bioactive PAs, and methods of use thereof. The disclosed PAs may be used in cell culture methods and in methods of treating central nervous system injury.

CPC Classifications

C12N 5/0062 C07K 7/64 C12M 21/08 C12M 25/14 C12N 5/0619 C12N 2533/50

Filing Date

2025-09-30

Application No.

19345142

View original document →

Named provisions

Netrin-1 mimetic peptide amphiphiles Nanofibers displaying bioactive PAs Methods of treating central nervous system injury

Get daily alerts for USPTO Patent Applications - Peptides (C07K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 2nd, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260092252A1

Who this affects

Applies to
Pharmaceutical companies Medical device makers Legal professionals
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Patent Applications
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Pharmaceuticals

Get alerts for this source

We'll email you when USPTO Patent Applications - Peptides (C07K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!